Quest Diagnostics, Inc [DGX] stock prices are up 2.66% to $168.72 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The DGX shares have gain 3.74% over the last week, with a monthly amount glided 10.29%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Quest Diagnostics, Inc [NYSE: DGX] stock has seen the most recent analyst activity on January 06, 2025, when Leerink Partners upgraded its rating to a Outperform and also boosted its price target to $174 from $169. Previously, Morgan Stanley upgraded its rating to Overweight on December 17, 2024, and elevated its price target to $172. Robert W. Baird upgraded its rating to a Outperform and increased its price target to $182 on October 23, 2024. Citigroup upgraded its rating to Buy for this stock on July 10, 2024, and upped its price target to $165. In a note dated February 26, 2024, Leerink Partners initiated an Market Perform rating and provided a target price of $135 on this stock.
The stock price of Quest Diagnostics, Inc [DGX] has been fluctuating between $123.30 and $168.17 over the past year. Currently, Wall Street analysts expect the stock to reach $178.14 within the next 12 months. Quest Diagnostics, Inc [NYSE: DGX] shares were valued at $168.72 at the most recent close of the market. An investor can expect a potential return of 5.58% based on the average DGX price forecast.
Analyzing the DGX fundamentals
The Quest Diagnostics, Inc [NYSE:DGX] reported sales of 9.87B for trailing twelve months, representing a surge of 14.55%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.13 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 165.80 points at the first support level, and at 162.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 170.46, and for the 2nd resistance point, it is at 172.19.
Ratios To Look Out For
It’s worth pointing out that Quest Diagnostics, Inc [NYSE:DGX]’s Current Ratio is 1.10. On the other hand, the Quick Ratio is 1.02, and the Cash Ratio is 0.25. Considering the valuation of this stock, the price to sales ratio is 1.91, the price to book ratio is 2.76 and price to earnings (TTM) ratio is 21.92.
Transactions by insiders
Recent insider trading involved Gregg Vicky B, Director, that happened on Feb 05 ’25 when 1250.0 shares were sold. SVP & Chief Commercial Officer, DELANEY MARK E completed a deal on Feb 05 ’25 to sell 403.0 shares. Meanwhile, Officer DELANEY MARK E bought 403.0 shares on Feb 05 ’25.
